Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Advertisers
    • Permissions
  • About Us
    • ISHRS
    • Forum
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Useful Sites
    • ISHRS

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Hair Transplant Forum International
  • Other Useful Sites
    • ISHRS
  • My alerts
  • Log in
Hair Transplant Forum International

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Advertisers
    • Permissions
  • About Us
    • ISHRS
    • Forum
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Follow ISHRS on Twitter
  • Visit ISHRS on Facebook
  • Follow ISHRS on LinkedIn
  • Follow ISHRS on Instagram
  • Follow ISHRS on YouTube
Research ArticleArticles

How I Do It: Galenic Lotions for Topical Use to Cure Hair Thinning in Males and Females

Timothy Carman, Piero Tesauro and Gaetano Agostinacchio
Hair Transplant Forum International September 2014, 24 (5) 170-172; DOI: https://doi.org/10.33589/24.5.0170
Timothy Carman
La Jolla, California, USA
MD, FISHRS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tcarmanmd@ljhr.com
Piero Tesauro
Milan, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pierotesauro@gmail.com
Gaetano Agostinacchio
Milan, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
  1. Timothy Carman, MD, FISHRS (tcarmanmd{at}ljhr.com)
    1. La Jolla, California, USA
  2. Piero Tesauro, MD (pierotesauro{at}gmail.com)
    1. Milan, Italy
  3. Gaetano Agostinacchio, MD
    1. Milan, Italy

Embedded Image

While transplantation is the cornerstone of our collective practices, medical therapy directed at mitigating ongoing thinning and subsequent loss is of critical importance in addressing our patients’ quality of life concerns related to the cosmetic appearance of overall hair density and/or fullness. At the most recent International Congress of The Brazilian Society of Hair Restoration Surgery held in Maresias, Brazil, I and my ISHRS colleagues in attendance appreciated Dr. Piero Tesauro’s presentation on his approach to medical therapy in the treatment of male and female pattern hair loss. Below, Dr. Tesauro details the treatment modalities he uses in his daily practice.

This article presents an approach utilized in our clinic employing galenic therapy for the medical management of commonly treated alopecias. Galenic therapy is defined as the use of prescription drugs not generally available directly to the public but that are prepared in a laboratory as requested by a physician or medical practice (this is also known as compounding). These compositions are a custom ensemble of individualized prescription medications that can be administered topically or orally. Following are examples of topical galenic therapies used to address commonly seen alopecias along with the subsequent clinical outcomes observed as a result of consistent use of each therapy.

Premise

The hair cycle is controlled by the circulating steroidal sex hormones that are metabolized by the follicle itself. Control of this hormone production can slow hair loss (Figure 1).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Androgen metabolism of the pilo sebaceous complex.

Pattern 1: Androgenetic Alopecia (AGA)

AGA is supported by a multigenetic family inheritance, the presence of androgen hormones in the plasma, and in particular the activity of the 5-alpha reductase enzyme in the hair follicle. The 5-alpha reduction of testosterone to dihydrotestosterone is in fact associated with the thinning of the hair on top of the head and a coincident retraction of the frontal hairline, both typical of AGA. Finasteride, which inhibits the enzyme 5-alpha reductase, type II, is used for oral therapy in these cases while minoxidil and progesterone are the topical therapy options:

ORAL THERAPY

  • Finasteride 1mg/Day

TOPICAL THERAPY:

  • Minoxidil 2%

  • Progesterone 1%

  • Transcutol 5%

  • Alcohol 80% to preference to adjust viscosity and drying

  • Distilled water to a volume of 200ml

Minoxidil. The second FDA-approved drug for the treatment of baldness is a peripheral vasodilator in which its capacity to stimulate the growth of hair was discovered around 1980. The mechanism of action of minoxidil is not yet clear. Pre-clinical studies suggest that minoxidil slows cellular senescence in a similar way to how the epidermal growth factor (EGF) prolongs the anagen phase of the hair growth cycle. This active principle seems to mimic the action of a growth factor stimulating the mitosis of the matrix.

Progesterone. Progesterone for local use inhibits the activity of 5-alpha reductase by competing with testosterone and reducing its conversion into dihydrotestosterone. Progesterone reaches the epidermal, dermal, and glandular tissues and is then metabolized in the pilosebaceous complex into an inactive derivative. Systemic absorption is not observed in clinical use.

Transcutol. Highly purified diethyene glycol monoethyl ether EP/NF is an agent that improves skin penetration of a drug. Safety has been demonstrated by extensive toxologic evaluations and it is used in approved pharmaceutical products. The lotion is less greasy. Transcutol does not have a long shelf life.

Pattern 2: Estrone Deficiency

A widespread clinical hypotrichia with centrifugal patterns corresponds to a type of alopecia called “estrone deficiency” (Dr. Andrea Marliani). Histologically, the hair in these cases decreases in its diameter but does not lose its follicular depth. It is assumed that this condition is in fact linked to a deficiency of estrone and in turn is connected to a possible reduction of activity of the enzyme aromatase and/or 3-alpha reductase. Therapy to address the mechanism in these cases is restricted mainly to topical corticosteroids:

  • Hydrocortisone butyrate 0.05%

  • Estrone basis 0.05%

  • Transcutol 5%

  • Alcohol 80% to preference

  • Distilled water to a volume of 200ml

Hydrocortisone butyrate (Cortisol). Activates neoglicogenesis in the cell matrix and papilla of the hair bulb and allows for the production of glycogen to ensure glucose homeostasis and energy of the hair. The use of a mild corticosteroid is also useful for controlling the erythema and desquamation, thus putting the skin in a condition to better receive the other topical therapies. A further property of that active ingredient is to counter the phenomena of fibrous scarring that occurs in all trichological pathologies leading to the permanent loss of the follicle.

Estrone basis. The estrone activates the enzyme adenyl cyclase activating glycolysis, with the production of energy in the form of ATP, and therefore promotes the mitosis of the cells of the matrix and the papilla. This hormone is therefore not only responsible for the maintenance of the anagen phase, but also the activation of bulge stem cells.

Pattern 3: Mixed Clinical Patterns

Mixed clinical patterns of AGA and estrone component deficiency are usually treated with the following formulation:

  • Minoxidil 2%

  • Progesterone 1%

  • Hydrocortisone butyrate 0.05%

  • Estrone basis 0.05%

Example of a prescription and its directions for use:

Galenic lotion for topical use:

  • Minoxidil 2%

  • Progesterone 1%

  • Hydrocortisone butyrate 0.05%

  • Estrone base

  • Transcutol 5%

  • Alcohol 80% to preference

  • Distilled water to a volume of 200ml

METHOD OF APPLICATION

In Pattern 1, the lotion is applied twice daily as usual (2ml). In Patterns 2 and 3, for many years we have used a different protocol of applying the lotion all over the scalp as follows (Figure 2):

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Application of the lotion: 1, frontal area; 2, central area; 3, vertex area; 4, left parietal/temporal zone; 5, right parietal/temporal zone.

INSTRUCTIONS

Apply 5ml of lotion (about 100 drops), 3 times a week on alternate days (e.g., Monday, Wednesday, and Fri-day) after shampooing.

The lotion should be applied to the following 5 areas of the scalp, 1ml (20 drops) at a time: 1ml on the frontal area, 1ml on the central area (the area between the front line and vertex), 1ml on the summit, 1ml on the right temporal/right parietal zone, and 1ml on the left temporal / left parietal zone.

Massage for 30 seconds with the fingertips to help the absorption of the lotion per ml used.

In summary: Run the shampoo; dab your hair with the towel; apply the lotion on the 5 areas of the scalp, massaging each part for 30 seconds after each ml applied; blow-dry your hair.

Examples of Pattern 2 clinical cases are shown in Figures 3, 4, and 5. Examples of Pattern 3 results obtained with galenic lotion in association with oral serenoa repens (saw palmetto) and finasteride are shown in Figures 6, 7, and 8.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Pattern 2 patient (estrone deficiency): before (left) and after (right) 2 years of treatment.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Pattern 2 patient (estrone deficiency): before (left) and after (right) 1 year of treatment.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Pattern 2 Patient (estron deficiency): before (left) and after (right) 2 years of treatment.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Pattern 3 patient progression over 13 months. Galenic lotion and oral serenoa repens and finasteride 0.25mg.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Pattern 3 patient: before (left) and after (right) 7 months (June 2013–January 2014). Galenic lotion and oral serenoa repens and finasteride 0.25mg.

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Pattern 3 patient: before (left) and after (right) 9 months (July 2013–March 2014). Galenic lotion and oral serenoa repens and finasteride 0.25mg.

It is often necessary in my clinical practice to use a reduced dose of finasteride (0.25mg.). Patients are often frightened by the use of Propecia® and dosage reduction is extremely soothing. While I have a feeling that the reduction of the dose (0.25) reduces side effects, I’m certain that it greatly reduces the nocebo effect.

We know that the efficacy of finasteride was demonstrated at doses of 0.2mg/day or higher. We also know that 1 and 5mg doses are of similar efficacy but somewhat superior to lower doses.

Although I agree that the use of a combination of finasteride and saw palmetto can be controversial, I consider three good reasons to do so:

  1. Serenoa repens strengthens the anti DHT finasteride action.

  2. The saw palmetto acts on 5-alpha reductase receptors type 1 and type 2.

  3. Many of the most popular over-the-counter supplements contain the serenoa repens in combination with other substances (minerals, vitamins, natural anti-inflammatory and antioxidants), which probably have a different mechanism of action than the finasteride itself. When I perceive the utility of these supplements, I will always include the serenoa.

I understand that these reasons are not supported by scientific clinical research as that would require a dou-ble-blind study. I hope soon to take a step forward in this direction but for now this is exactly is “How I do it”… with good results!

  • Copyright © 2014 by The International Society of Hair Restoration Surgery

Bibliography

  1. 1.
    Piraccini, B.M., and A. Alessandrini. Androgenic alopecia. G Ital Dermatol Venereol. 2014(Feb); 149(1):15-24. Review.
    OpenUrlPubMed
  2. 2.
    Yip, L., et al. Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Br J Dermatol. 2009(Aug); 161(2):289-94. doi: 10.1111/j.1365-2133.2009.09186.x. Epub 2009 Apr 29. PMID:19438456
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

International Society of Hair Restoration Surgery: 24 (5)
Hair Transplant Forum International
Vol. 24, Issue 5
September/October 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Hair Transplant Forum International.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How I Do It: Galenic Lotions for Topical Use to Cure Hair Thinning in Males and Females
(Your Name) has sent you a message from Hair Transplant Forum International
(Your Name) thought you would like to see the Hair Transplant Forum International web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
How I Do It: Galenic Lotions for Topical Use to Cure Hair Thinning in Males and Females
Timothy Carman, Piero Tesauro, Gaetano Agostinacchio
Hair Transplant Forum International Sep 2014, 24 (5) 170-172; DOI: 10.33589/24.5.0170

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
How I Do It: Galenic Lotions for Topical Use to Cure Hair Thinning in Males and Females
Timothy Carman, Piero Tesauro, Gaetano Agostinacchio
Hair Transplant Forum International Sep 2014, 24 (5) 170-172; DOI: 10.33589/24.5.0170
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Premise
    • Bibliography
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • ABHRS President’s Corner
  • Call for Co-Editors
  • President’s Message
Show more Articles

Similar Articles

Navigate

  • Home
  • Current
  • Archives

General Information

  • Authors
  • Advertisers
  • Permissions

About

  • ISHRS
  • Forum
  • Editorial Board

Follow Us On

  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • YouTube

© 2025 Hair Transplant Forum International

Powered by HighWire